1005–1012.
37 37 Fedirko, V., Tramacere, I., Bagnardi, V. et al. (2011). Alcohol drinking and colorectal cancer risk: an overall and dose‐response meta‐analysis of published studies. Annals of Oncology 22 (9): 1958–1972.
38 38 Mahabir, S., Leitzmann, M.F., Virtanen, M.J. et al. (2005). Prospective study of alcohol drinking and renal cell cancer risk in a cohort of finnish male smokers. Cancer Epidemiology, Biomarkers & Prevention 14 (1): 170–175.
39 39 Rashidkhani, B., Akesson, A., Lindblad, P., and Wolk, A. (2005). Alcohol consumption and risk of renal cell carcinoma: a prospective study of Swedish women. International Journal of Cancer 117 (5): 848–853.
40 40 Lee, J.E., Hunter, D.J., Spiegelman, D. et al. (2007). Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. Journal of the National Cancer Institute 99 (10): 801–810.
41 41 Psaltopoulou, T., Sergentanis, T.N., Ntanasis‐Stathopoulos, I. et al. (2018). Alcohol consumption and risk of hematological malignancies: a meta‐analysis of prospective studies. International Journal of Cancer 143 (3): 486–495.
42 42 Stornetta, A., Guidolin, V., and Balbo, S. (2018). Alcohol‐derived acetaldehyde exposure in the oral cavity. Cancers 10 (1): pii: E20.
43 43 Park, S.M., Li, T., Wu, S. et al. (2017). Risk of second primary cancer associated with pre‐diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma. Cancer Epidemiology 47: 106–113.
44 44 Turati, F., Garavello, W., Tramacere, I. et al. (2013). A meta‐analysis of alcohol drinking and oral and pharyngeal cancers: results from subgroup analyses. Alcohol and Alcoholism 48 (1): 107–118.
45 45 Alexandrov, L.B., Ju, Y.S., Haase, K. et al. (2016). Mutational signatures associated with tobacco smoking in human cancer. Science 354 (6312): 618–622.
46 46 Druesne‐Pecollo, N., Keita, Y., Touvier, M. et al. (2014). Alcohol drinking and second primary cancer risk in patients with upper aerodigestive tract cancers: a systematic review and meta‐analysis of observational studies. Cancer Epidemiology, Biomarkers & Prevention 23 (2): 324–331.
47 47 Simapivapan, P., Boltong, A., and Hodge, A. (2016). To what extent is alcohol consumption associated with breast cancer recurrence and second primary breast cancer?: a systematic review. Cancer Treatment Reviews 50: 155–167.
48 48 Park, S.M., Li, T., Wu, S. et al. (2017). Risk of second primary cancer associated with pre‐diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma. Cancer Epidemiology 47: 106–113.
49 49 Knight, J.A., Fan, J., Malone, K.E. et al. (2017). Alcohol consumption and cigarette smoking in combination: a predictor of contralateral breast cancer risk in the WECARE study. International Journal of Cancer 141 (5): 916–924.
50 50 Yokoyama, A. and Omori, T. (2005). Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers exit disclaimer. Alcohol 35 (3): 175–185.
51 51 Baker, F., Ainsworth, S.R., Dye, J.T. et al. (2000). Health risks associated with cigar smoking. Journal of the American Medical Association 284 (6): 735–740.
52 52 Kozlowski, L.T., Dollar, K.M., and Giovino, G.A. (2008). Cigar/cigarillo surveillance: limitations of the U.S. Department of agriculture system. American Journal of Preventive Medicine 34 (5): 424–426.
53 53 Tynan, M.A., Holmes, C.B., Promoff, G. et al. (2016). State and local comprehensive smoke‐free laws for worksites, restaurants, and bars – United States, 2015. MMWR. Morbidity and Mortality Weekly Report 65 (24): 623–626.
54 54 Tsai, J., Homa, D.M., Gentzke, A.S. et al. (2018). Exposure to secondhand smoke among nonsmokers United States, 1988–2014. MMWR. Morbidity and Mortality Weekly Report 67: 1342–1346.
55 55 Jha, P., Ramasundarahettige, C., Landsman, V. et al. (2013). 21st‐century hazards of smoking and benefits of cessation in the United States. New England Journal of Medicine 368 (4): 341–350.
56 56 Nash, S.H., Liao, L.M., Harris, T.B., and Freedman, N.D. (2017). Cigarette smoking and mortality in adults aged 70 years and older: results from the NIH‐AARP cohort. American Journal of Preventive Medicine 52 (3): 276–283.
57 57 Hecht, S.S. (2003). Tobacco carcinogens, their biomarkers and tobacco‐induced cancer. Nature Reviews Cancer 3 (10): 733–744.
58 58 Austoni, E., Mirone, V., Parazzini, F. et al. (2005). Smoking as a risk factor for erectile dysfunction: data from the andrology prevention weeks 2001–2002. A study of the Italian Society of Andrology (S.I.A.). European Urology 48 (5): 810–818.
59 59 Hatsukami, D.K., Stead, L.F., and Gupta, P.C. (2008). Tobacco addiction. Lancet 371 (9629): 2027–2038.
60 60 Piano, M.R., Benowitz, N.L., Fitzgerald, G.A. et al. (2010). Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 122 (15): 1520–1544.
61 61 Villanti, A.C., Richardson, A., Vallone, D.M., and Rath, J.M. (2013). Flavored tobacco product use among U.S. young adults. American Journal of Preventive Medicine 44 (4): 388–391.
62 62 Walter, V., Jansen, L., Hoffmeister, M., and Brenner, H. (2014). Smoking and survival of colorectal cancer patients: systematic review and meta‐analysis. Annals of Oncology 25 (8): 1517–1525.
63 63 Warren, G.W., Kasza, K.A., Reid, M.E. et al. (2013). Smoking at diagnosis and survival in cancer patients. International Journal of Cancer 132 (2): 401–410.
64 64 Parsons, A., Daley, A., Begh, R., and Aveyard, P. (2010). Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta‐analysis. British Medical Journal 340: b5569.
65 65 Travis, L.B., Rabkin, C.S., Brown, L.M. et al. (2006). Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. Journal of the National Cancer Institute 98 (1): 15–25.
66 66 Peto, R., Darby, S., Deo, H. et al. (2000). Smoking, smoking cessation, and lung cancer in the U.K. since 1950: combination of national statistics with two case‐control studies. British Medical Journal 321 (7257): 323–329.
67 67 Inoue‐Choi, M., Hartge, P., Liao, L.M. et al. (2018). Association between long‐term low‐intensity cigarette smoking and incidence of smoking‐related cancer in the National Institutes of Health‐AARP cohort. International Journal of Cancer 142 (2): 271–280.
68 68 Prignot, J.J., Sasco, A.J., Poulet, E. et al. (2008). Alternative forms of tobacco use. The International Journal of Tuberculosis and Lung Disease 12 (7): 718–727.
69 69 Smith‐Simone, S., Maziak, W., Ward, K.D., and Eissenberg, T. (2008). Waterpipe tobacco smoking: knowledge, attitudes, beliefs, and behavior in two U.S. samples. Nicotine & Tobacco Research 10 (2): 393–398.
70 70 Corey, C.G., Ambrose, B.K., Apelberg, B.J., and King, B.A. (2014). Flavored tobacco product use among middle and high school students‐‐United States. MMWR Morbidity and Mortality Weekly Report 2015 64 (38): 1066–1070.
71 71 Henley, S.J., Thun, M.J., Chao, A., and Calle, E.E. (2004). Association between exclusive pipe smoking and mortality from cancer and other diseases. Journal of the National Cancer Institute 96 (11): 853–861.
72 72 Wyss, A., Hashibe, M., Chuang, S.C. et al. (2013). Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. American Journal of Epidemiology 178 (5): 679–690.
73 73 Fontham, E.T.H., Wolf, A.M.D., Church, T.R. et al. (2020). Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: A Cancer Journal for Clinicians 70 (5): 321–346.
74 74 Leyden, W.A., Manos, M.M., Geiger, A.M. et al. (2005). Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. Journal of the National Cancer Institute 97 (9): 675–683.
75 75